~ The life-saving dual MitraClip and TAVR procedures were performed by Dr. Sai Satish on a 75 year
who was brought to us in a critical condition
~ In yet another milestone for the hospital, Dr. Sai Satish and his team performed
9 TAVRs and 3 MitraClips within a span of 24 hours
Chennai, March 30, 2022: Apollo Hospitals, Asia’s largest and most trusted healthcare group, saw
yet another landmark with Asia’s first dual implant of MitraClip and Transcatheter Aortic Valve
Replacement (TAVR) being performed on the same patient. A 75-year-old male patient from Sri
Lanka was admitted in cardiogenic shock with severe Aortic stenosis and Mitral Valve regurgitation.
This was further complicated by a cardiac arrest after admission.
This necessitated a milestone procedure of replacing the aortic valve (TAVR) and repairing the mitral
valve (MitraClip), which was performed by Dr Sai Satish, Senior Interventional Cardiologist at Apollo
An additional milestone saw Dr Sai Satish successfully completing 9 TAVRs and 3 MitraClips in a span
of 24 hours. All the patients recovered within 48 hours of the procedure.
TAVR is the ideal procedure for patients with severe and symptomatic aortic stenosis with the
invention of a revolutionary valve constructed from a combination of metal mesh and animal tissue,
delivered via a thin tube (catheter) through an artery in the leg and then expanded in place.
The MitraClip procedure repairs leaking mitral valves by clipping its leaflets of the valve together.
These minimally invasive MitraClip and TAVR procedures enable the repair/replacement of damaged
heart valves without open heart surgery. Following the procedure, the recovery is so rapid that most
patients can be discharged within 24 to 48 hours. MitraClip and TAVR procedures are lifesaving
procedures for patients at high surgical risk.
Dr. Sai Satish, Senior Interventional Cardiologist, Apollo Hospitals said, “We have been pioneering
the use of cutting-edge medical innovations like MitraClip procedures for almost four years now and
TAVR even longer. We have done the highest number of cases in the country. It is this experience
and of course the infrastructure and support service of the hospital that enabled us to save this
patient’s life by performing both the TAVR and the MitraClip to fix both his valves. The TAVR fixed
the narrowed aortic valve that was severely calcified, while the torrential mitral regurgitation was
fixed using the MitraClip implant.
“Right after this we continued to perform 3 MitraClip and 9 TAVR procedures back-to-back in some
very sick patients in a period of just 24 hours. More than just being a first, or breaking any records,
this demonstrates the confidence patients have in these of life enhancing procedures.”
Dr Prathap C. Reddy, Chairman, Apollo Hospitals Group said, “It is a matter of great pride that we
are achieving new milestones becoming the first in Asia to perform MitraClip and TAVR procedures
in the same patient and also in having the capacity to seamlessly perform such a large number of
complex cases in just 24 hours. However, it is more important to celebrate the fact that these
procedures are allowing us to save lives of patients who cannot go in for open heart surgery because
of high risk due to age and other reasons. These cutting-edge procedures allow patients to return to
a quality of life that they used to enjoy before their problems began. This is a testament to our
experience and excellence in this domain with around 70% of all MitraClips in India to date having
been performed at Apollo Hospitals.”
Heart disease is now the leading killer of men and women in the country. There are approximately
26 million cases of heart failure diagnosed around the world, and it is estimated that in India alone
there are about 4-5 million cases. Such patients are known to have a life-long struggle and a very
high mortality of up to 60% in five years; and mitral regurgitation can be a significant component in
such cases, worsening outcomes in heart failure patients.
Apollo Hospitals is at the forefront in making new minimally invasive therapies in cardiovascular
disease management available for patients as they become the standard of care for patients with
heart failure with moderate to severe or severe primary & secondary heart valve problems who are
not improving on medical treatment.
Dr. Sai Satish who has performed over 450 TAVR implants across the world and also has the highest
number of MitraClip implants in India, further added, “The MitraClip and TAVR are remarkable
innovations that both, dramatically improve quality of life and increase life expectancy in
appropriate patient subsets.”